ACE and type 2 diabetes mellitus: Specific benefits may be expected with the useof angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptorblockers (ARB) for HT and SGLT2 inhibitors for T2D, as previously addressed, dueto their renoprotective effects [72].